Component
Mouse histamine-producing neurons
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Histamine-neuron ablation or acute chemogenetic inhibition shortened, but did not abolish, modafinil-induced wakefulness in mice.
Experimental context and source evidence
- evidence_access
- Full XML obtained; relevant results/methods inspected. Not exhaustive reanalysis of figures or data.
- experimental_condition
- Modafinil with intact neurons ablated or inhibited · Mouse histamine-producing neurons Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_condition
- Modafinil with intact neurons drug challenge · Modafinil Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_contrast
- {"intervention": "Histamine-neuron ablation/inhibition plus modafinil", "comparator": "Modafinil with intact neurons", "endpoint": "Histamine-neuron ablation or acute chemogenetic inhibition shortened, but did not abolish, modafinil-induced wakefulness in mice.", "effect_direction": "decrease", "combination": "joint", "conditions": [{"entity_slug": "mouse-histamine-neurons", "state": "ablated or inhibited"}, {"entity_slug": "modafinil", "state": "drug challenge"}]} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Mouse genetic and chemogenetic experiments; cell dependency not direct drug binding.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
- plain_language
- Histamine-neuron ablation or acute chemogenetic inhibition shortened, but did not abolish, modafinil-induced wakefulness in mice.
- primary_references
- Genetic lesioning of histamine neurons increases sleep-wake fragmentation and reveals their contribution to modafinil-induced wakefulness. | 2019 | DOI 10.1093/sleep/zsz031 | PMID 30722053 | https://pmc.ncbi.nlm.nih.gov/articles/PMC6519916/
- source_locator
- Reviewed reference lines 79-79; exact primary location described in quoted passage where extracted.
Modafinil: detailed mechanisms of action (reviewed 3 October 2026) · lines 79–79
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Mouse genetic and chemogenetic experiments; cell dependency not direct drug binding. · Recorded from source · Recorded from source
Genetic removal or acute chemogenetic inhibition of histamine neurons shortened modafinil-induced waking in mice rather than abolishing it. Histamine-neuron activity therefore contributes to sustained wakefulness in that setting, without being established as the direct drug target. Recovery sleep still showed increased NREM delta power, including after histamine-neuron ablation: a homeostatic response persisted. [Histamine-neuron study, 2019](https://pmc.ncbi.nlm.nih.gov/articles/PMC6519916/)
Complete structured claim and evidence
Where it participates (unsigned role)
Recovery sleep showed increased NREM delta power after modafinil, including after histamine-neuron ablation; prolonged waking did not remove this homeostatic response.
Experimental context and source evidence
- evidence_access
- Full XML obtained; relevant results/methods inspected. Not exhaustive reanalysis of figures or data.
- experimental_contrast
- {"intervention": "Post-modafinil recovery sleep", "comparator": "Study baseline/control", "endpoint": "Recovery sleep showed increased NREM delta power after modafinil, including after histamine-neuron ablation; prolonged waking did not remove this homeostatic response.", "effect_direction": "increase", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Mouse recovery sleep; intact and histamine-neuron-ablated conditions.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
- plain_language
- Recovery sleep showed increased NREM delta power after modafinil, including after histamine-neuron ablation; prolonged waking did not remove this homeostatic response.
- primary_references
- Genetic lesioning of histamine neurons increases sleep-wake fragmentation and reveals their contribution to modafinil-induced wakefulness. | 2019 | DOI 10.1093/sleep/zsz031 | PMID 30722053 | https://pmc.ncbi.nlm.nih.gov/articles/PMC6519916/
- source_locator
- Reviewed reference lines 79-79; exact primary location described in quoted passage where extracted.
Modafinil: detailed mechanisms of action (reviewed 3 October 2026) · lines 79–79
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Mouse recovery sleep; intact and histamine-neuron-ablated conditions. · Recorded from source · Recorded from source
Genetic removal or acute chemogenetic inhibition of histamine neurons shortened modafinil-induced waking in mice rather than abolishing it. Histamine-neuron activity therefore contributes to sustained wakefulness in that setting, without being established as the direct drug target. Recovery sleep still showed increased NREM delta power, including after histamine-neuron ablation: a homeostatic response persisted. [Histamine-neuron study, 2019](https://pmc.ncbi.nlm.nih.gov/articles/PMC6519916/)
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.